ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1164508
BOSTON, MA
Position in HALO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$133,420,842
+$9,450,873 QoQ
Shares Held
1,704,623
-11.1% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#16
of 666 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,515,799,583 across 71 Biotechnology names. HALO ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
738,378 | $366,774,503 | |
| 2 | INCY |
Incyte Corp
|
2,744,958 | $311,168,438 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
393,685 | $245,478,344 | |
| 4 | EXEL |
Exelixis, Inc.
|
4,365,926 | $237,550,033 | |
| 5 | GMAB |
Genmab A/S
|
4,975,324 | $136,672,150 | |
| 6 | RPRX |
Royalty Pharma plc
|
2,435,341 | $136,549,569 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,704,623 | $133,420,842 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
249,758 | $71,173,537 |
All Filings in HALO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,420,842 | 1,704,623 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $123,969,969 | 1,918,149 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $216,874,721 | 3,222,507 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $241,337,371 | 3,290,665 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $132,192,235 | 2,541,181 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $71,180,501 | 1,115,507 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $47,469,927 | 992,887 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $23,549,222 | 411,412 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,379,937 | 102,749 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $280,651 | 6,899 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $3,866,260 | 101,211 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 | $10,739,657 | 271,615 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,004,844 | 159,201 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $16,928,575 | 416,140 | Shares | Defined | 2021-11-12 | |
| 2020-09-30 | $1,666,152 | 63,400 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $334,696 | 12,484 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,872,705 | 104,097 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||